Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 72 13
Montelukast Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/11/2020 3 0
Darunavir Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/26/2020 5 1
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 5 1
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 6 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 10 1
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/24/2020 3 0
Raltegravir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/06/2020 5 0
Dolutegravir Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/26/2020 4 0